Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     Respiratory & Anesthesia Devices     Respiratory diagnostic     Polysomnography (PSG) Device    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

European Polysomnography (PSG) Device Market

  • Report Code: PO 1001
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The European polysomnography (PSG) device market, mainly driven by the enormous patient base of obstructive sleep apnea (OSA), accompanied by technological amelioration of well-designed clinical and ambulatory PSG devices, was valued at $526.2 million in 2013, and is expected to reach $1.0 billion by 2018, at a CAGR of 14.2% from 2013 to 2018. The clinical polysomnography (PSG) devices segment constitutes the largest share of the polysomnography (PSG) devices market.

The report analyzes the market of devices in terms of 2 segments, namely, clinical and ambulatory polysomnography (PSG) devices. These segments experienced a substantial positive growth till 2013, owing to the elevated momentum in the awareness levels among the care givers and patients. The clinical PSG devices segment has been contributing nearly 60.2%, in terms of value, towards the total sleep apnea diagnostic devices. In terms of volume (units), the ambulatory PSG devices segment holds a prime stand in the total sleep apnea diagnostic devices industry. Both the markets have been witnessing the maximum growth, mainly because of the increase in the patient pool and the rise in the incidence of obstructive sleep apnea (OSA).

Germany accounts for the largest market share in the European PSG devices market, owing to the increasing healthcare awareness for sleep apnea, rising disposable incomes, improving healthcare infrastructure, economic growth favored by broadening insurance coverage, and the increasing cases of obesity that are adding to the pool of sleep apnea patients. Major players such as Philips Respironics have been sponsoring public awareness campaigns and health workshops to provide educational training to the medical professionals in Europe. In recent years, the European Sleep Research Society and the World Sleep Foundation have included major sleep apnea manufacturers in these awareness campaigns. According to the European Sleep Apnea Database (ESADA), by March 2014, the number of enrolled patients reached 15,956, along with 5313 follow-up visits.

The report also provides a detailed competitive landscaping of the leading companies operating in this market. The segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies are also detailed in this report. The main companies covered in the report include Natus Medical, Inc., Compumedics, Ltd., Philips Respironics, CleveMed, Inc. and other companies.

 

Customization Options:

Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and deep dive analysis of the following parameters:

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (segment-wise)
  • Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country and sub-segment levels
  • End-user adoption rate analysis of the products (segment-wise and country-wise)
  • A comprehensive coverage of product approvals, pipeline products, and product recalls

 

Epidemiology Data

  • Country-specific prevalence of obstructive sleep apnea (OSA)
  • Country-specific patient pool of obstructive sleep apnea (OSA)
  • Disease progression (pattern analysis)

 

 Ancillary Data

  • The number of unit sales, along with the respective ASPs, and the number of surgeries performed annually in each country, tracked till sub-segment level
  • Usage data and purchasing data
  • Healthcare expenditure across the region
  • The number of hospitals, home healthcare units, and clinics

 

Surgeons’/Physicians’ Perception analysis

  • Fast turn-around analysis of surgeons’ responses to market events and trends
  • Pattern analysis of usage of PSG devices by physicians
  • Surgeons’ opinions about products from different companies
  • Surgeons’ qualitative inputs on epidemiology data

 

Brand/Product Perception Matrix

  • A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool (digital marketing language) checking the virality and tonality of blogs
  • An analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar) regarding the market

 

Competitive Intelligence

  • Company share analysis of the key players forecast till 2018 across the sub-segments and countries in the market
  • Developing business strategies to enhance the bottom line of the companies


1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Polysomnography (PSG) Device-Europe, By Types
4.1 Ambulatory Polysomnography (PSG) Device-Europe
4.2 Clinical Polysomnography (PSG) Device-Europe

Please fill in the form below to receive a free copy of the Summary of this Report
















European Polysomnography (PSG) Device Market

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Connect With Us
US/CAN : +1-888-502-0539